RMC-4550

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRMC-4550
Drug Alias NameRMC-4550
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitorsProtein allosteric inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevolution Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevolution Medicines Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A